Technology

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.

Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.

The free virtual event will bring together healthcare, technology and policy stakeholders to discuss digital transformation, AI, rural broadband and advocacy.

The company has filed to list its Class A shares as it looks to scale its AI- and blockchain-enabled telehealth platform after U.S. expansion and private financing.

Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

The company was granted a preliminary injunction blocking U.S. sales of an alleged copycat fitness tracker by Chinese company Shenzhen Lexqi Electronic Technology Co.

The company will use the funding for research and development, to launch new agentic AI tools across multiple modalities, and to scale its engineering, product and growth teams.

Alex Richter of SciTech Innovation Hub, which won the World Economic Forum’s 2025 Public-Private Collaboration Award, joined MobiHealthNews to discuss emerging technologies.